JPM or MS: Which Investment Banking Powerhouse is the Better Buy Now?

The article positions JPMorgan (JPM) as a superior investment banking play compared to Morgan Stanley (MS), citing JPM's leading global IB fee market share, 36% fee growth in 2024, and its diversified revenue streams, including significant net interest income and a trading arm that benefits from market volatility. While MS also saw strong 2024 IB growth and is expanding its stable wealth management segment, its 2025 IB performance has been more subdued. JPM further demonstrates stronger investment metrics, trading at a lower forward P/E (14.52x vs. MS's 15.56x) with a higher ROE (16.93% vs. 15.20%) and outperforming YTD stock gains (20.8% vs. 14.4%), despite analysts projecting higher near-term revenue and earnings growth for MS.

Analysis

JPMorgan (JPM) and Morgan Stanley (MS) are both benefiting from a resurgence in deal-making and heightened market volatility, though their recent performance and strategic positioning present a divergent picture. JPMorgan demonstrates superior current momentum in its core Investment Banking (IB) division, with fees growing 10% year-over-year in the first half of 2025, capturing a leading 8.9% global wallet share. This contrasts with Morgan Stanley, whose IB revenue growth has been subdued at just 1% in the same period. JPM's diversified model, where nearly half of revenue stems from a stable and growing Net Interest Income base projected at $95.5 billion for 2025, provides a significant cushion against IB cyclicality. In contrast, MS is successfully executing a strategic pivot towards wealth and asset management, which now comprises over 55% of total net revenues. On a valuation and performance basis, JPMorgan currently appears more attractive, with a year-to-date share price gain of 20.8% versus 14.4% for MS, a lower forward P/E ratio of 14.52x compared to MS's 15.56x, and a higher ROE of 16.93% versus 15.20%. However, a key counterpoint is the forward outlook, where analyst consensus projects significantly stronger growth for Morgan Stanley in 2025, with expected revenue and earnings increases of 8.3% and 10.9% respectively, compared to a marginal decline forecast for JPMorgan.

Key Decisions for Investors

• Investors prioritizing current performance, valuation, and a diversified business model may find JPMorgan a more compelling investment, given its leadership in investment banking, superior ROE, lower P/E multiple, and the stability provided by its massive net interest income stream.
• Morgan Stanley could appeal to growth-oriented investors who are willing to look past its recent subdued IB performance, focusing instead on the strong analyst consensus for double-digit earnings growth in 2025 and the long-term strategic success of its pivot to wealth management.
• Both firms' trading revenues are benefiting from market volatility linked to tariff policies; investors should monitor these geopolitical developments, as a decrease in volatility could temper trading income while potentially accelerating a broader recovery in M&A and underwriting, altering the near-term earnings dynamic for both banks.